바이오뱅크 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global biobanking market size is expected to reach USD 19.35 Billion in 2034 from USD 8.39 Billion in 2025, growing at a CAGR of 9.73% during 2026-2034.The biobanking market is poised for significant growth, driven by the increasing demand for biological samples and data for research and clinical applications. Biobanks play a crucial role in supporting biomedical research by providing access to a wide range of biological materials, including blood, tissue, and DNA samples. As the global focus on personalized medicine and genomics intensifies, the demand for biobanking services is expected to rise, positioning this market for robust expansion.

Moreover, advancements in biobanking technologies are driving innovation within the market. The development of automated sample processing, storage solutions, and data management systems is enhancing the efficiency and reliability of biobanks. These innovations not only improve sample integrity and accessibility but also facilitate the integration of biobanking with advanced research methodologies, such as high-throughput sequencing and bioinformatics. As research continues to explore new applications for biobanking, the market is likely to expand further, driven by the promise of improved research outcomes and collaboration.

Additionally, the growing emphasis on ethical considerations and regulatory compliance is shaping the biobanking landscape. As biobanks navigate complex ethical frameworks and regulations regarding sample collection and usage, the demand for transparent and compliant biobanking practices is likely to increase. This trend is particularly relevant in the context of patient consent and data privacy, where maintaining trust and transparency is essential. As the biobanking market continues to evolve, the combination of technological advancements, ethical considerations, and a focus on collaboration will play a crucial role in shaping its future trajectory.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

• Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
• Consumables ( Storage Consumables, Analysis Consumables, Processing, Consumables, Collection Consumables)
• Services
• Software

By Sample Type

• Blood Products
• Human Tissues
• Cell Lines
• Nucleic Acids
• Biological Fluids
• Human Waste Products

By Storage Type

• Manual Storage
• Automated Storage

By Ownership

• Universities
• National/Regional Agencies
• Non-Profit Organizations
• Private Organizations

By Application

• Regenerative Medicine
• Life Science Research
• Clinical Research

By End user

• Pharmaceutical & Biotechnology Companies and CROs
• Academic & Research Institutes
• Hospitals

COMPANIES PROFILED

• Thermo Fisher Scientific, QIAGEN, Brooks Life Sciences, Azenta, Hamilton Company, Tecan, BioLife Solutions, Eppendorf, Merck KGaA, Danaher, BioCision, Taylor-Wharton, PHC Holdings, Panasonic Healthcare, ASKION, BioRep, Sampled, Discovery Life Sciences, ProteoGenex, Coriell Institute

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOBANKING MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables ( Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOBANKING MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample Type
• 5.2. Blood Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Human Tissues Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cell Lines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Biological Fluids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Human Waste Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOBANKING MARKET: BY STORAGE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Storage Type
• 6.2. Manual Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOBANKING MARKET: BY OWNERSHIP 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Ownership
• 7.2. Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. National/Regional Agencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Non-Profit Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Private Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOBANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Life Science Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BIOBANKING MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Pharmaceutical & Biotechnology Companies and CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL BIOBANKING MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product & Service
  • 10.2.2 By Sample Type
  • 10.2.3 By Storage Type
  • 10.2.4 By Ownership
  • 10.2.5 By Application
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product & Service
  • 10.3.2 By Sample Type
  • 10.3.3 By Storage Type
  • 10.3.4 By Ownership
  • 10.3.5 By Application
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Spain
  • 10.3.12 Russia
  • 10.3.13 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product & Service
  • 10.4.2 By Sample Type
  • 10.4.3 By Storage Type
  • 10.4.4 By Ownership
  • 10.4.5 By Application
  • 10.4.6 By End User
  • 10.4.7 China
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 India
  • 10.4.11 Australia
  • 10.4.12 South East Asia
  • 10.4.13 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product & Service
  • 10.5.2 By Sample Type
  • 10.5.3 By Storage Type
  • 10.5.4 By Ownership
  • 10.5.5 By Application
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product & Service
  • 10.6.2 By Sample Type
  • 10.6.3 By Storage Type
  • 10.6.4 By Ownership
  • 10.6.5 By Application
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL BIOBANKING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Thermo Fisher Scientific
  • 12.2.2 QIAGEN
  • 12.2.3 Brooks Life Sciences
  • 12.2.4 Azenta
  • 12.2.5 Hamilton Company
  • 12.2.6 Tecan
  • 12.2.7 BioLife Solutions
  • 12.2.8 Eppendorf
  • 12.2.9 Merck KGaA
  • 12.2.10 Danaher
  • 12.2.11 BioCision
  • 12.2.12 Taylor-Wharton
  • 12.2.13 PHC Holdings
  • 12.2.14 Panasonic Healthcare
  • 12.2.15 ASKION
  • 12.2.16 BioRep
  • 12.2.17 Sampled
  • 12.2.18 Discovery Life Sciences
  • 12.2.19 ProteoGenex
  • 12.2.20 Coriell Institute